NIAID investigators are seeking Washington, D.C.-area, healthy volunteers ages 18 to 49 for a clinical study that will test the safety of and immune response to a new, live virus vaccine against the H5N1 influenza virus. This study is being conducted at the NIH Clinical Center in Bethesda, Maryland.
Read more about the study:
open here please
Phase 1 Study of Safety and Immunogenicity of AD4-H5-VTN in AD4 Seronegative Volunteers
.png)
No hay comentarios:
Publicar un comentario